Immunocell Therapy Market Report – Research, Industry Analysis Reports and Market Demands

Global Immunocell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope of Immunocell Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Immunocell Therapy by Type
- 1.3.1 Overview: Global Immunocell Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Immunocell Therapy Consumption Value Market Share by Type in 2023
- 1.3.3 Chimeric Antigen Receptor (CAR) T Cell Therapy
- 1.3.4 Natural Killer (NK) Cell Therapy
- 1.3.5 Others
1.4 Global Immunocell Therapy Market by Application
- 1.4.1 Overview: Global Immunocell Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.4.4 Others
1.5 Global Immunocell Therapy Market Size & Forecast
1.6 Global Immunocell Therapy Market Size and Forecast by Region
- 1.6.1 Global Immunocell Therapy Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Immunocell Therapy Market Size by Region, (2019-2030)
- 1.6.3 North America Immunocell Therapy Market Size and Prospect (2019-2030)
- 1.6.4 Europe Immunocell Therapy Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Immunocell Therapy Market Size and Prospect (2019-2030)
- 1.6.6 South America Immunocell Therapy Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Immunocell Therapy Market Size and Prospect (2019-2030)

2 Company Profiles

3 Market Competition, by Players

3.1 Global Immunocell Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Immunocell Therapy by Company Revenue
- 3.2.2 Top 3 Immunocell Therapy Players Market Share in 2023
- 3.2.3 Top 6 Immunocell Therapy Players Market Share in 2023
3.3 Immunocell Therapy Market: Overall Company Footprint Analysis
- 3.3.1 Immunocell Therapy Market: Region Footprint
- 3.3.2 Immunocell Therapy Market: Company Product Type Footprint
- 3.3.3 Immunocell Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Immunocell Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Immunocell Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

5.1 Global Immunocell Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global Immunocell Therapy Market Forecast by Application (2025-2030)

6 North America

6.1 North America Immunocell Therapy Consumption Value by Type (2019-2030)
6.2 North America Immunocell Therapy Consumption Value by Application (2019-2030)
6.3 North America Immunocell Therapy Market Size by Country
- 6.3.1 North America Immunocell Therapy Consumption Value by Country (2019-2030)
- 6.3.2 United States Immunocell Therapy Market Size and Forecast (2019-2030)
- 6.3.3 Canada Immunocell Therapy Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Immunocell Therapy Market Size and Forecast (2019-2030)

7 Europe

7.1 Europe Immunocell Therapy Consumption Value by Type (2019-2030)
7.2 Europe Immunocell Therapy Consumption Value by Application (2019-2030)
7.3 Europe Immunocell Therapy Market Size by Country
- 7.3.1 Europe Immunocell Therapy Consumption Value by Country (2019-2030)
- 7.3.2 Germany Immunocell Therapy Market Size and Forecast (2019-2030)
- 7.3.3 France Immunocell Therapy Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Immunocell Therapy Market Size and Forecast (2019-2030)
- 7.3.5 Russia Immunocell Therapy Market Size and Forecast (2019-2030)
- 7.3.6 Italy Immunocell Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific

8.1 Asia-Pacific Immunocell Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Immunocell Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Immunocell Therapy Market Size by Region
- 8.3.1 Asia-Pacific Immunocell Therapy Consumption Value by Region (2019-2030)
- 8.3.2 China Immunocell Therapy Market Size and Forecast (2019-2030)
- 8.3.3 Japan Immunocell Therapy Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Immunocell Therapy Market Size and Forecast (2019-2030)
- 8.3.5 India Immunocell Therapy Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Immunocell Therapy Market Size and Forecast (2019-2030)
- 8.3.7 Australia Immunocell Therapy Market Size and Forecast (2019-2030)

9 South America

9.1 South America Immunocell Therapy Consumption Value by Type (2019-2030)
9.2 South America Immunocell Therapy Consumption Value by Application (2019-2030)
9.3 South America Immunocell Therapy Market Size by Country
- 9.3.1 South America Immunocell Therapy Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Immunocell Therapy Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Immunocell Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa

10.1 Middle East & Africa Immunocell Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Immunocell Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Immunocell Therapy Market Size by Country
- 10.3.1 Middle East & Africa Immunocell Therapy Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Immunocell Therapy Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Immunocell Therapy Market Size and Forecast (2019-2030)
- 10.3.4 UAE Immunocell Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics

11.1 Immunocell Therapy Market Drivers
11.2 Immunocell Therapy Market Restraints
11.3 Immunocell Therapy Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Immunocell Therapy Industry Chain
12.2 Immunocell Therapy Upstream Analysis
12.3 Immunocell Therapy Midstream Analysis
12.4 Immunocell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Immunocell Therapy market size was valued at USD 1930.3 million in 2023 and is forecast to a readjusted size of USD 4386.3 million by 2030 with a CAGR of 12.4% during review period.
Immune therapy is a new class of cancer treatment designed to boost or enhance the body’s immune system to more efficiently target and destroy cancerous cells. Many experts believe that immunotherapy represents the most promising new cancer treatment since the development of chemotherapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Immunocell Therapy industry chain, the market status of Hospitals (Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), Clinics (Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Immunocell Therapy.
Regionally, the report analyzes the Immunocell Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Immunocell Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Immunocell Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Immunocell Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Immunocell Therapy market.
Regional Analysis: The report involves examining the Immunocell Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Immunocell Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Immunocell Therapy:
Company Analysis: Report covers individual Immunocell Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Immunocell Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Immunocell Therapy. It assesses the current state, advancements, and potential future developments in Immunocell Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Immunocell Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Immunocell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chimeric Antigen Receptor (CAR) T Cell Therapy
Natural Killer (NK) Cell Therapy
Others
Market segment by Application
Hospitals
Clinics
Others
Market segment by players, this report covers
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immunocell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immunocell Therapy, with revenue, gross margin and global market share of Immunocell Therapy from 2019 to 2024.
Chapter 3, the Immunocell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Immunocell Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immunocell Therapy.
Chapter 13, to describe Immunocell Therapy research findings and conclusion.

Buy now